iNtRON Biotechnology, Inc. (KOSDAQ: 048530)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,390.00
-70.00 (-1.28%)
Dec 20, 2024, 9:00 AM KST
-39.10%
Market Cap 176.36B
Revenue (ttm) 8.61B
Net Income (ttm) -4.82B
Shares Out 32.72M
EPS (ttm) -145.53
PE Ratio n/a
Forward PE n/a
Dividend 100.00 (1.86%)
Ex-Dividend Date Dec 27, 2024
Volume 131,067
Open 5,540.00
Previous Close 5,460.00
Day's Range 5,300.00 - 5,750.00
52-Week Range 4,460.00 - 9,300.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 17, 2025

About iNtRON Biotechnology

iNtRON Biotechnology, Inc. engages in the development of novel drugs in South Korea. It develops bacteriophage and endolysin based drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Employees 76
Stock Exchange KOSDAQ
Ticker Symbol 048530
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.